- You are here: Home
- Disease Models
- Rare Disease Models
Disease Models
- Oncology Models
-
Inflammation & Autoimmune Disease Models
- Rheumatoid Arthritis Models
- Glomerulonephritis Models
- Multiple Sclerosis (MS) Models
- Ocular Inflammation Models
- Sjögren's Syndrome Model
- LPS-induced Acute Lung Injury Model
- Peritonitis Models
- Passive Cutaneous Anaphylaxis Model
- Delayed-Type Hypersensitivity (DTH) Models
- Inflammatory Bowel Disease Models
- Systemic Lupus Erythematosus Animal Models
- Asthma Model
- Sepsis Model
- Psoriasis Model
- Atopic Dermatitis (AD) Model
- Scleroderma Model
- Gouty Arthritis Model
- Carrageenan-Induced Air Pouch Synovitis Model
- Carrageenan-Induced Paw Edema Model
- Experimental Autoimmune Myasthenia Gravis (EAMG) Model
- Cardiovascular Disease Models
-
Neurological Disease Models
- Alzheimer's Disease Modeling and Assays
- Seizure Models
- Parkinson's Disease Models
- Ischemic Stroke Models
- Acute Spinal Cord Injury (ASCI) Model
- Traumatic Brain Injury (TBI) Model
- Hypoxic-Ischemic Encephalopathy (HIE) Model
- Tourette Syndrome (TS) Model
- Amyotrophic Lateral Sclerosis (ALS) Model
- Huntington's Disease (HD) Model
- Intracerebral hemorrhage (ICH) Models
- Pain Models
- Metabolic Disease Models
- Liver Disease Models
- Rare Disease Models
- Respiratory Disease Models
- Digestive Disease Models
-
Urology Disease Models
- Cisplatin-induced Nephrotoxicity Model
- Unilateral Ureteral Obstruction Model
- 5/6 Nephrectomy Model
- Renal Ischemia-Reperfusion Injury (RIRI) Model
- Diabetic Nephropathy (DN) Models
- Passive Heymann Nephritis (PHN) Model
- Adenine-Induced Chronic Kidney Disease (CKD) Model
- Kidney Stone Model
- Doxorubicin-Induced Nephropathy Model
- Orthopedic Disease Models
- Ocular Disease Models
Rare Disease Models
There are several known rare diseases and more unknown diseases are being identified in specific patient populations. Unfortunately, there is a lack of treatment and even understanding of the mechanisms of most rare diseases. In order to meet the increasing needs of clinical treatment, it is essential to increase the research on rare diseases and the development of successful drugs. These studies rely heavily on animal models of disease in vivo.
Animal model of rare disease is an important part of the study of rare diseases because it has a complete physiological state that allows therapy to be evaluated in a more meaningful context. Although animal models do not generally represent about diseases, they can express many disease characteristics similar to those of human patients.
Creative Bioarray has developed stable and efficient preclinical disease models that can be helpful in the clinical study of rare diseases.
Our rare disease models cover the following diseases
- Huntington's disease
- Amyotrophic lateral sclerosis (ALS)
- Batten disease
- Multiple sclerosis (MS)
- Systemic lupus erythematosus (SLE)
- Muscular dystrophy
In addition, we can also use appropriate endpoints to study disease mechanisms, such as imaging, gait and movement, and cognitive testing.
Data & Figures
Figure 1. Neurotoxin models of Huntington's disease
Our team provides drug discovery services from target identification to IND enabled safety and toxicology service. We have extensive experience in developing disease models based on scientific publications.
Quotation and ordering
To discuss any of these models further or to discuss the possibility of developing alternative models, please do not hesitate to contact us.
Reference
- Rangel-Barajas. Overview of Huntington’s Disease Models: Neuropathological, Molecular, and Behavioral Differences. Curr. Protoc. Neurosci. 83, e47 (2018).
For research use only. Not for any other purpose.
